Abeona Therapeutics (PCJ) Ownership - Who Owns Abeona Therapeutics?
Abeona Therapeutics (PCJ) Ownership Overview
- 6.19% Insiders
- 6.76% Mutual Funds
- 0.68% Other Institutional Investors
- 9.12% ETFs
- 77.25% Public Companies and Individual Investors
The ownership structure of Abeona Therapeutics (DE:PCJ) stock is a mix of institutional, retail, and individual investors. Approximately 16.56% of the company’s stock is owned by Institutional Investors, 6.19% is owned by Insiders, and 77.25% is owned by Public Companies and Individual Investors.
The ownership structure of Abeona Therapeutics (DE:PCJ) stock is a mix of institutional, retail, and individual investors. Approximately 16.56% of the company’s stock is owned by Institutional Investors, 6.19% is owned by Insiders, and 77.25% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 28, 2026 | Vishwas Seshadri | $100,981 | |
| Sep 28, 2026 | Joseph Walter Vazzano | $47,334 | |
| Sep 28, 2026 | Brendan M. O'malley | $34,644 | |
| Sep 28, 2026 | Madhav Vasanthavada | $25,245 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Deerfield Management Company, Lp | €210,800 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 3,352,474 | Institution | 5.86% | 15,002,321 |
| Vanguard | 2,396,726 | Institution | 4.19% | 10,725,349 |
| Vanguard Index Funds | 2,156,795 | Institution | 3.77% | 9,651,658 |
| Ishares | 1,860,964 | Institution | 3.25% | 8,327,814 |
| Vishwas Seshadri | 1,286,500 | Insider | 2.25% | 5,757,088 |
| Fidelity Concord Street Trust | 597,979 | Institution | 1.05% | 2,675,956 |
| Fidelity Salem Street Trust | 548,031 | Institution | 0.96% | 2,452,439 |
| Joseph Walter Vazzano | 482,888 | Insider | 0.84% | 2,160,924 |
| Brendan M. O'malley | 421,226 | Insider | 0.74% | 1,884,986 |
| Vanguard Scottsdale Funds | 293,187 | Institution | 0.51% | 1,312,012 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,156,795 | Institution | 3.77% | 9,651,658 |
| Fidelity Concord Street Trust | 597,979 | Institution | 1.05% | 2,675,956 |
| Fidelity Salem Street Trust | 548,031 | Institution | 0.96% | 2,452,439 |
| Vanguard Scottsdale Funds | 293,187 | Institution | 0.51% | 1,312,012 |
| Schwab Capital Trust | 128,932 | Institution | 0.23% | 576,971 |
| Tiaa-cref Funds | 56,719 | Institution | 0.10% | 253,818 |
| Goldman Sachs Trust | 34,310 | Institution | 0.06% | 153,537 |
| Vanguard Valley Forge Funds | 27,928 | Institution | 0.05% | 124,978 |
| Vanguard Institutional Index Funds | 26,710 | Institution | 0.05% | 119,527 |
| State Street Institutional Investment Trust | 22,200 | Institution | 0.04% | 99,345 |
FAQ
Who Owns Abeona Therapeutics (DE:PCJ)?
According to the latest TipRanks data, approximately 16.56% of the company's stock is held by institutional investors, 6.19% is held by insiders, and 77.25% is held by public companies and individual investors.
What percentage of Abeona Therapeutics (DE:PCJ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.56% of Abeona Therapeutics (DE:PCJ) stock is held by institutional investors: 6.76% by mutual funds, 9.12% by ETFs and 0.68% by other institutional investors.
What percentage of Abeona Therapeutics (DE:PCJ) stock is held by retail investors?
According to the latest TipRanks data, approximately 77.25% of Abeona Therapeutics (DE:PCJ) stock is held by public companies and individual investors.
Who owns the most shares of Abeona Therapeutics (DE:PCJ)?
BlackRock, Inc. owns the most shares of Abeona Therapeutics (DE:PCJ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
